chimeric antigen receptor
Scope
Date
~
-
Bio & Pharma
JLK gets FDA OK for prostate cancer diagnosis AI solution
South Korea’s JLK Inc., an AI-based diagnosis solution and platform maker, announced on Monday that it got approval from the US Food and Drug ...
Jun 25, 2024 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio receives FDA approval for phase 1,2 trials of LCB84
South Korean pharmaceutical firm LegoChem Biosciences Inc. announced on Thursday that it has received approval from the US Food and Drug Administrat...
Jun 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Vaxcell-Bio, Cellid sign MOU to build cancer immunotherapy platform
Vaxcell-Bio Therapeutics, a South Korean company specializing in anti-cancer immunotherapy, announced on Wednesday its partnership with Cellid Co. t...
Feb 15, 2023 (Gmt+09:00)
Latest News
- 1 BYD’s Atto 3 overtakes Tesla’s Model Y as best-selling EV in South Korea
- 2 Korea’s top cinema chains seek merger to counter box office slump
- 3 S.Korea’s GEPS to commit $143 million to foreign mid-cap buyout funds
- 4 CJ CheilJedang to open $72 mn dumpling plant in Japan
- 5 LG Electronics breaks ground on $600 million home appliance plant in India